A Phase I Study With a Personalized Neoantigen Cancer Vaccine in Glioblastoma Multiforme

AFFECTION_STATUS - Affectation status of the subject for Glioblastoma (GBM); All subjects are GBM patients. (phv00527726.v1.p1)
ANALYTE_TYPE - Analyte type (phv00396007.v2.p1)
BODY_SITE - Body site where sample was collected (phv00396006.v2.p1)
CONSENT - Consent group as determined by DAC (phv00395996.v2.p1)
ETHNICITY - Ethnicity of subject (phv00396004.v2.p1)
HISTOLOGICAL_TYPE - Cell or tissue type (phv00396008.v2.p1)
IS_TUMOR - Tumor status of the sample (phv00396009.v2.p1)
SAMPID - De-identified sample ID (phv00396005.v2.p1)
SAMPID - De-identified sample ID (phv00395999.v2.p1)
SUBJID - De-identified subject ID (phv00396001.v2.p1)
SUBJID - De-identified subject ID (phv00395995.v2.p1)
SUBJID - De-identified subject ID (phv00395998.v2.p1)